Stocks TelegraphStocks Telegraph
Stock Ideas

CPIX Company Profile and Key Details

NASDAQ : CPIX

Cumberland Pharmaceuticals Inc.

$5.08
1.32+35.11%
At Close 4:00 PM
$6.16
1.08+21.26%
After-Market 07:58 PM
69.83
BESG ScoreESG Rating

CPIX Stock Price Chart

Stock Price Today

Cumberland Pharmaceuticals Inc. (CPIX) stock surged +35.11%, trading at $5.08 on NASDAQ, up from the previous close of $3.76. The stock opened at $3.84, fluctuating between $3.84 and $6.43 in the recent session.

Stock Snapshot

3.76
Prev. Close
3.84
Open
71.33M
Market Cap
14.04M
Number of Shares
3.84
Day Low
6.43
Day High
-6.68
P/E Ratio
55.83%
Free Float in %
-0.76
EPS (TTM)
2.09
Book Value
0.4
Cash Flow per Share
59.43M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 05, 20253.846.433.845.0859.5M
Feb 04, 20252.353.792.213.7616.79M
Feb 03, 20252.162.262.082.1359.51K
Jan 31, 20252.292.382.212.2640.6K
Jan 30, 20252.202.522.202.2523.4K
Jan 29, 20252.332.382.212.2420.21K
Jan 28, 20252.322.502.302.3624.97K
Jan 27, 20252.462.532.332.3624.8K
Jan 24, 20252.572.592.452.5910.4K
Jan 23, 20252.632.632.502.5026.02K
Jan 22, 20252.412.632.412.6226.53K
Jan 21, 20252.522.602.432.4357.03K
Jan 17, 20252.812.842.502.5368K
Jan 16, 20252.732.952.702.77127.83K
Jan 15, 20252.622.982.502.74366.4K
Jan 14, 20252.303.932.292.677.47M
Jan 13, 20252.342.382.272.3322.2K
Jan 10, 20252.242.402.232.3399.8K
Jan 08, 20252.382.382.212.2340.8K
Jan 07, 20252.352.502.262.37118.53K

Contact Details

Nashville, TN 37203

United States

Website: https://www.cumberlandpharma.comContact: 615 255 0068

About Company

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate that is in Phase II clinical trial for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Company Information

Employees91
Beta0.22
Sales or Revenue$39.55M
5Y Sales Change%0.057%
Fiscal Year EndsDecember
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Frequently Asked Questions

What is the current Cumberland Pharmaceuticals Inc. (CPIX) stock price?

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) stock price is $5.08 in the last trading session. During the trading session, CPIX stock reached the peak price of $6.43 while $3.84 was the lowest point it dropped to. The percentage change in CPIX stock occurred in the recent session was 35.11% while the dollar amount for the price change in CPIX stock was $1.32.

CPIX's industry and sector of operation?

The NASDAQ listed CPIX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Cumberland Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CPIX?

Ms. Cindy B. Patton
Senior Director of Field Marketing
Ms. Jean W. Marstiller
Senior Vice President of Admin. Services & Corporation Sec.
Mr. A. J. Kazimi MBA
Founder, Chairman, Pres & Chief Executive Officer
Mr. John Michael Hamm
Chief Financial Officer
Ms. Erin Smith Gull
Senior Corporation Relations Associate
Mr. Todd M. Anthony
Vice President of Organizational Devel.
Mr. James Lowrance Herman
Executive Vice President of National Accounts & Chief Compliance Officer
Mr. Chris T. Bitterman
Vice President of Sales & Marketing

How CPIX did perform over past 52-week?

CPIX's closing price is 388.46% higher than its 52-week low of $1.04 where as its distance from 52-week high of $6.43 is -21%.

How many employees does CPIX have?

Number of CPIX employees currently stands at 91.

Link for CPIX official website?

Official Website of CPIX is: https://www.cumberlandpharma.com

How do I contact CPIX?

CPIX could be contacted at phone 615 255 0068 and can also be accessed through its website. CPIX operates from 2525 West End Avenue, Nashville, TN 37203, United States.

How many shares of CPIX are traded daily?

CPIX stock volume for the day was 59.43M shares. The average number of CPIX shares traded daily for last 3 months was 2.07M.

What is the market cap of CPIX currently?

The market value of CPIX currently stands at $71.33M with its latest stock price at $5.08 and 14.04M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph